The potential error caused by the interfering substance is compared to the allowable error as stated in the CLSI EP7-A2 guideline. Interference was determined by measuring HbA1c in samples containing increasing proportions of lipemia (up to 500 mg/dL), bilirubin (up to 15 mg/dL), and vitamin C (up to 3 mg/dL).
Free full text: Click here